COMMUNIQUÉS West-GlobeNewswire

Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
01/10/2026
DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Balt Announces First Patients Enrolled in Silk Vista Baby™ PIONEER Study
01/10/2026
IRVINE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Balt announced today it has enrolled the first patients in North America in the premarket approval (PMA) clinical trial, PIONEER ( PI votal Study O f the Silk Vista Baby [...]
Alignment Health Expands Access to Personalized Senior Care in 2027 with New Markets, Provider Networks and Medicare Advantage Plan Options
01/10/2026
Alignment Health expands into San Antonio, Charlotte and California's Central Valley, bringing its high-tech, high-touch care model to nearly 9.5 million Medicare-eligible seniors across five states ORANGE, Calif., Oct [...]
HealthLynked Selects DRCARE247 as Telemedicine Partner to Expand Integrated Virtual Care Platform
01/10/2026
NAPLES, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ), a healthcare technology company focused on AI-powered patient engagement, care coordination, and provider connectivity, today [...]
Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026
01/10/2026
BOSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today announced that the company will present new [...]
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
01/10/2026
SpyGlass Pharma acquires 100% of the outstanding shares of AVS, a subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), the existing manufacturer of SpyGlass Pharma’s intraocular lens (IOL) Secures scalable commercial [...]
ViCentra Presents Large-Scale Real-World Evidence Demonstrating Kaleido Insulin Patch Pump System Delivers Stable Glucose Control with Very Low Hypoglycemia
01/10/2026
Analysis of 3,918 adults across Germany, the Netherlands and France, with no eligibility criteria beyond active system use, covering 323,814 person-days of real-world experience Users achieved median time in range of 72 [...]
60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
01/10/2026
Interim analysis results from clinical study evaluating tafenoquine in severe babesiosis ( NCT06207370 ) to be disclosed on October 6, 2026. Key Opinion Leader investor webinar scheduled for October 6, 2026, featuring [...]
BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026
01/10/2026
LOUISVILLE, Ky., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2026 financial results on [...]
Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days
01/10/2026
PLYMOUTH MEETING, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present a poster featuring information from its ongoing Phase 3 trials of HBS-301, [...]
Medicana Highlights Robotic Prostate Surgery as 2026 Review Reports Recovery Benefits
01/10/2026
ISTANBUL, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Medicana Health Group is highlighting the role of robot-assisted surgery in prostate cancer treatment as a 2026 research review reports lower blood loss and shorter hospital [...]
New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)
01/10/2026
New codes streamline hospital billing, enable tracking of clinical outcomes, and expand access to QUELIMMUNE ® (SCD-PED) therapy Universal codes establish a framework to enable billing for future potential SCD [...]
Akari Therapeutics Expands Intellectual Property Portfolio with PCT Filing for ADC Payload Related to RNA Splicing in Cancers
01/10/2026
Patent filing covers PH1 payload’s unique ability to disrupt multiple cancer-driving pathways in addition to its overall cytotoxic mechanism Expands intellectual property portfolio supporting Akari’s novel payload and [...]
ViroMissile Completes First Dose Cohort of Phase I Trial of Intravenously-Dosed IDOV-2; Safety Review Committee Clears Advancement to Next Cohort
01/10/2026
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- ViroMissile , Inc., a cancer immunotherapy company pioneering the IDOV™ (Intravenously Deliverable Oncolytic Virus) platform, today announced the completion of the first dose [...]
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
01/10/2026
Presentations will feature encore Phase 1 data highlighting the mechanism of action, redosing potential, and early C-peptide response associated with SAB-142, a fully human multi-specific ATG for Stage 3 type 1 diabetes [...]
Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and Feet
01/10/2026
DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
01/10/2026
Agreement establishes an initial 100-device commercialization program for the ANVISA-approved Nexalin Sync™ across seven countries and more than 300 million people, with a structured pricing framework and a mechanism [...]
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
01/10/2026
Brings public company CFO experience across commercial pharma and business development as Achieve prepares for potential commercialization of cytisinicline SEATTLE and VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE [...]
TOMI Environmental Solutions Expands SteraMist iHP into India's Pharmaceutical Market Through Partner STS Technocrat (India) Pvt. Ltd.
01/10/2026
STS Technocrat (India) Pvt. Ltd. signs a leading pharmaceutical customer and is building an integrated SteraMist iHP enclosure with TOMI to support growth across India FREDERICK, Md. , Oct. 01, 2026 (GLOBE NEWSWIRE) -- [...]

Pages